InfuSystem (INFU) Posts Strong Profit Growth; Upside Visualized In Determine Inc (DTRM)


InfuSystem Holdings, Inc. (NYSEMKT:INFU) stock surged in pre-market trade Wednesday after the company delivered significant growth in its quarterly financial results

For the fourth quarter 2015, InfuSystem posted net revenue of $19.5 million, a 20% increase year over year, and net income of $2.0 million, or $0.09 per diluted share versus a net income of $1.0 million, or $0.05 per diluted share in the same period the prior year

INFU stock closed at $3.22, down $0.09 (or -2.72%), with a total volume of 85,061 shares traded on Tuesday

InfuSystem Holdings, a leading provider of infusion pumps and related services, has 22.51M Shares Outstanding, Market Capitalization (intraday) of $72.50M and INFU stock one-year range is from $2.22 to $3.71 per share



Investment analysts at Maxim Group initiated coverage on Determine, Inc. (Nasdaq:DTRM) with a Buy rating and a price target of $4.50 per share, representing an upside potential of more than 181% over its price at close on Tuesday of $1.60 per share

Determine recently reported third quarter fiscal 2016 non-GAAP revenue of $7.2 million, a 14% increase year over year

Determine, which provides enterprise contract management, supply management, and configuration solutions, has 11.14M Shares Outstanding, Market Capitalization (intraday) of $17.82M and DTRM stock 52-week range is between $1.39 and $7.99 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at